2005
DOI: 10.1205/fbp.04395
|View full text |Cite
|
Sign up to set email alerts
|

Optimizing Bioreactor Productivity for Therapeutic Immune Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Manual sampling, coupled with at-line and off-line measurements is routinely performed to measure other process parameters such as cell density, viability, and metabolites concentrations [ 11 ]. The lack of process understanding has prevented the development of suitable mechanistic models which still have major discrepancies between predictions and experimental data [ 153 ].…”
Section: Comparison Of Currently Available Act Bioreactor Technologiementioning
confidence: 99%
“…Manual sampling, coupled with at-line and off-line measurements is routinely performed to measure other process parameters such as cell density, viability, and metabolites concentrations [ 11 ]. The lack of process understanding has prevented the development of suitable mechanistic models which still have major discrepancies between predictions and experimental data [ 153 ].…”
Section: Comparison Of Currently Available Act Bioreactor Technologiementioning
confidence: 99%